The ESG in Life Sciences Summit West - Mastering ESG Compliance & Strategic Sustainability in Life Sciences in 2025. As ESG becomes a key differentiator for securing business and investment, life sciences companies are ramping up sustainability efforts - expanding teams, funding new initiatives, and integrating ESG into corporate strategy. Yet, with shifting global reporting […]

“Toxicity is the killer of ADCs” and remains the primary challenge limiting ADC success in the clinic. From unpredictable off-target effects to non-translating toxicity profiles and dose limiting toxicities, the industry must address key hurdles in preclinical models, patient selection, ADC design, and cross-disciplinary communication to accelerate the next wave of safer, more effective ADCs. The […]

The 3rd Obesity & Weight Loss Summit has been announced and is set to ignite the field.  The summit will unite experts to harness novel targets and GLP combination therapies to improve efficacy, tolerability, and longer lasting clinical outcomes. Join us at this unique, industry-led summit to: Discover groundbreaking combination therapies and novel targets to minimize and manage side […]

Building on recent breakthroughs in gene therapy, 2025 is poised for major advancements in cell transplants, gamma secretase inhibitors, anti-inflammatory programs, and more to address the growing unmet need for more transformative hearing loss treatments. With an aging population and an urgent need to restore a greater spectrum of hearing abilities beyond the scope of […]

The mRNA field is on the cusp of revolutionary change, with cancer vaccines, in vivo cell engineering and gene editing technologies unleashing the next advancements of therapeutic candidates and developmental progress towards clinical and commercial approval. To shine light on emerging areas and the latest progress, the 5th mRNA-Based Therapeutics Summit returns to Boston as the world's largest, end-to-end mRNA conference, […]

This July, the 13th Tumor Models Summit Boston returns, uniting 180+ preclinical and translational experts from biopharma and solution providers. This year’s dual-track program will empower you and your team to implement reproducible, predictive oncology models, and bridge the translational gap in a time- and cost-effective manner. Expect to gain exclusive insights into: The latest […]

As demand for radiopharmaceuticals rises, the industry is focused on strengthening isotope supply, improving patient access, and accelerating therapeutic development. Join us at the 4th Targeted Radiopharmaceuticals Summit US in San Diego this July for the premier platform dedicated to radiopharmaceutical therapeutics and theranostics, featuring: 50+ Expert Speakers from leading biotech, pharma, and research institutions, including Ratio […]

The Operationalize: Expanded Access Programs Summit West is coming to San Francisco! (July 29-31). Following the successful Boston and London meetings, the Operationalize Expanded Access Programs Summit West is uniting stakeholders executing Early Access, Expanded Access and Post-Trial Access Programs to share expertise in successfully bridging the gap between innovative clinical research and patients in need. This Summit is […]

The landscape of Fc-mediated therapies is undergoing a radical transformation, driven by precise Fc-receptor targeting and antibody domain modification to unlock new levels of efficacy and safety for unprecedented therapeutic potential in oncology and autoimmune disease treatment. The 5th Fc-Mediated Function Summit is the essential destination for experts driving innovation in Fc-receptor targeting and antibody […]

The 5th Next Generation Gene Therapy Vectors Summit Recent announcements from major pharmaceutical companies scaling back their AAV gene therapy pipelines have raised concerns across the field. However, this is not the end. It is an opportunity to reset, refocus, and rise to the challenge. While issues such as liver toxicity, pre-existing antibodies, and high manufacturing costs remain significant, so […]

Join us this August in Boston, MA for the 9th LEAP HR: Life Sciences East. Connect with 200+ leadership professionals in biopharma dedicated to attracting, retaining and developing critical talent to deliver their organizations mission. Engage with HR leaders who are also navigating a period of uncertainty amongst: regulation changes, financial uncertainties, supply chain disruptions, […]

As dual-payload and novel MoA payload ADCs continue to reshape the therapeutic landscape, the 3rd ADC Linker & Conjugation Summit returns as the definitive forum for ADC chemists and bioconjugation specialists aiming to overcome persistent challenges in hydrophobicity, aggregation, and linker stability. This three-day technical deep dive is your chance to: Discover next-generation conjugation strategies and site-specific […]

This August, the 9th IPF Summit returns as the industry’s must attend summit, providing an essential platform for the entire community to gather and dissect the latest breakthroughs and setbacks, to shape the future of pulmonary fibrosis drug development. Be one of the first to view the agenda here: https://ter.li/moky9n A Snapshot of What Awaits […]

In a year where neurology has overtaken cancer as the number one indication prioritized by oligonucleotide drug developers, now is the time to stay at forefront of ASO and siRNA innovation. Returning to Boston, this August, the 5th Oligonucleotides for CNS Summit unites 100+ biopharma leaders across RNA biology, oligonucleotide chemistry, DMPK, pharmacology, and platform […]

Engage in the Latest Innovations in Wearable Injectors and Connected Devices! SAE Media Group’s 3rd Annual Wearable Injectors and Connected Devices USA Conference returns to Boston on September 8–9, 2025, bringing together the latest innovations in connected, on-body drug delivery. Designed for professionals in injectable drug delivery and digital health, this two-day event will explore critical advancements in large-volume drug delivery, digital integration, […]

The 4th PAT & Real Time Quality Summit is the leading industry-specific forum for Process Analytical Technology (PAT) professionals in the biotech and pharmaceutical sectors. Taking place at a pivotal time, with the recent release of USP General Chapter <1037> and anticipated FDA guidelines on PAT due in July 2025, this summit is tailored to help organizations […]

Refine your strategy, sharpen your positioning, and meet the right partners - all at the most efficient networking event of the ADC conference calendar. Back for its second year, the ADC Partnering & Investment Summit unites 100+ top ADC companies, pharma leaders, and investors for hyper-aligned and more efficient business networking. Unite with other ADC business development […]

Fuelled by industry excitement like the world-first approval of a digital pathology CDx, the biomarker and diagnostics field continues to surge. Uniting 600+ precision medicine experts this September, the 15th World Clinical Biomarkers & Companion Diagnostics Summit returns with a refreshed 4-day, 3-track, 50+-speaker program, ready to facilitate connection-making and knowledge-sharing to bring affordable precision […]

Showcasing biopharma innovation in 2025, the 7th Exosome-Based Therapeutics Development Summit returns to Boston as the industry’s only dedicated forum covering the full exosome development pipeline, from discovery and optimized characterization to scalable manufacturing and clinical translation. This year’s Summit brings together key players from Direct Biologics, Rion, Aegle Therapeutics, Aruna Bio, EXO Biologics, and […]

With baby KJ successfully receiving the world’s first personalized CRISPR therapy, alongside continued innovation across in vivo and base editing, and rapid ex vivo clinical progress, the genome editing field stands at a pivotal juncture. To mark this definitive CRISPR milestone, the 6th Genome Editing Therapeutics Summit returns to Boston to celebrate ongoing progress, whilst […]

As 2025 shapes up to be a transformative year for talent acquisition in life sciences, the 7th LEAP TA: Life Sciences returns to Boston, MA this September (29 - October 1), uniting over 120 senior TA professionals from industry pioneers including Pfizer, AbbVie, Bristol Myers Squibb, Bayer, Edwards Lifesciences, The Jackson Laboratory, and more. This is […]

The 9th MASH Drug Development Summit is the definitive meeting for pharma and biotech leaders advancing the next generation of therapies for MASH. With the approval of Rezdiffra signaling a new era, the race is on to deliver more effective, patient-centered treatments. This year, dive into novel mechanisms of action, non-invasive biomarkers, and strategic combination […]

Unlock the future of cell and gene therapy manufacturing at the 2nd Raw Materials for Cell & Gene Therapy Summit. This is your exclusive opportunity to hear directly from regulatory and standards leaders such as Andrew Sarafanov (FDA) and Rebecca Potts (USP), as they share the latest thinking on BLA review expectations, raw material characterization, […]

Driving Analytical Excellence from Pre-IND Through BLA for Next-Generation Gene Therapies Returning to Boston this October, the 7th Gene Therapy Analytical Development Summit is the industry’s definitive meeting for advancing assay development and analytical strategy across the gene therapy lifecycle. As gene therapy platforms expand beyond AAV to encompass mRNA, CRISPR-based modalities, LNPs, and novel […]

The 3rd Spatial Biology for Drug Development Summit is your opportunity to come together with leading biopharma experts to address these challenges within the spatial biology space head-on. Across an intensive 2-day agenda, you’ll explore practical solutions to issues spanning data infrastructure, multi-omics integration, standardization, scalability, and translation into the clinic. This year’s forum will […]

With CMS introducing new guidance for RWD studies, the FDA announcing a new RWE Center, and RWD becoming more accessible, it is clear that RWE will play an increasingly pivotal role in the drug development lifecycle. But uncertainties still remain for the experts applying RWE. Returning to Boston, the 13th IMPACCT Real-World Evidence Summit is […]

 Returning as the industry’s definitive forum from early discovery to clinical development, the 8th Annual TPD & Induced Proximity Summit is the world’s largest and longest-standing forum for proximity-based modalities, enabling you to fully immerse yourself in the breadth and depth of cutting-edge induced proximity therapeutic development. Featuring key leaders such as Arvinas, Nurix Therapeutics, C4 Therapeutics, and […]

The rare disease trial landscape stands at a pivotal tipping point. While unprecedented advances in trial design, digital tools, and regulatory flexibility are accelerating innovation like never before, the reality for patients remains stark: over 90% of rare diseases still lack an FDA-approved treatment. For many, clinical trials represent the only path to care, yet […]

Funding pressures, regulatory shifts, global competition, and relentless layoffs are redefining the pre-commercial biopharma landscape. In this climate, agile, transparent, and people-first leadership is critical to keeping teams engaged, culture strong, and organizations moving forward. LEAP HR: Emerging Biopharma is the only meeting built for senior HR leaders in this space. Over three days in […]

Industry’s Flagship Forum Capturing Advancements Across Discovery, Preclinical, Translational, Clinical & Regulatory Development of Innovative Neuropsychiatric Therapeutics Uniting 150+ discovery, preclinical, translational, clinical, and regulatory leaders, the 8th Neuropsychiatric Drug Development Summit returns to provide you with an unrivaled opportunity to stay attuned to the latest progress while tackling industry’s most pressing challenges across a wide spectrum of mental health indications. […]